Clinical Trial

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Study acronym: CoMTBEV
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 24, 2025 (before its estimated February 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
Tick-borne encephalitis is a relatively rare disease (approximately 35 cases diagnosed per year), but most cases (86%) are due to contamination in France via a tick bite. Of the 71 cases reported over two years (May 2021 to May 2023), 94% of patients were hospitalized. It is therefore important to consider and diagnose at the first signs to ensure appropriate follow-up and also to implement primary prevention in endemic/at-risk areas.
Trial Details
NCT Number NCT07191223
Lead Sponsor University Hospital, Strasbourg, France
Conditions Tick-borne Encephalitis, France
Enrollment 100 participants
Start Date 2024-02-16
Primary Completion 2026-02-16 (estimated)
Study Completion 2026-02-16 (estimated)
Updated on ClinicalTrials.gov 2025-09-24